Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127194941 | 12719494 | 1 | I | 20130130 | 20160829 | 20160907 | 20160907 | EXP | JP-ROCHE-1826090 | ROCHE | 72.91 | YR | M | Y | 51.00000 | KG | 20160907 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127194941 | 12719494 | 1 | PS | Denosine (Japan) | GANCICLOVIR | 1 | Intravenous drip | 19661 | .25 | G | POWDER FOR INFUSION | BID | |||||||
127194941 | 12719494 | 2 | SS | Denosine (Japan) | GANCICLOVIR | 1 | Intravenous drip | 19661 | .25 | G | POWDER FOR INFUSION | BID | |||||||
127194941 | 12719494 | 3 | SS | Denosine (Japan) | GANCICLOVIR | 1 | Intravenous drip | 19661 | .25 | G | POWDER FOR INFUSION | BID | |||||||
127194941 | 12719494 | 4 | SS | Denosine (Japan) | GANCICLOVIR | 1 | Intravenous drip | 19661 | .25 | G | POWDER FOR INFUSION | BID | |||||||
127194941 | 12719494 | 5 | SS | LECTISOL | DAPSONE | 1 | Oral | Y | 0 | 50 | MG | BID | |||||||
127194941 | 12719494 | 6 | SS | MINOMYCIN | MINOCYCLINE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | BID | ||||||||
127194941 | 12719494 | 7 | SS | MINOMYCIN | MINOCYCLINE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | BID | ||||||||
127194941 | 12719494 | 8 | SS | MINOMYCIN | MINOCYCLINE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | BID | ||||||||
127194941 | 12719494 | 9 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 10 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 11 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 12 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 13 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 14 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 15 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 16 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 17 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 18 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 19 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | ||||||||||
127194941 | 12719494 | 20 | C | NICOTINAMIDE | NIACINAMIDE | 1 | Oral | 0 | 2 | G | TID | ||||||||
127194941 | 12719494 | 21 | C | FAMOTIDINE D | FAMOTIDINE | 1 | Oral | 0 | 20 | MG | BID | ||||||||
127194941 | 12719494 | 22 | C | VENOGLOBULIN IH | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | 0 | |||||||||||
127194941 | 12719494 | 23 | C | ACHROMYCIN V | TETRACYCLINE HYDROCHLORIDE | 1 | Oral | 0 | 250 | MG | TID | ||||||||
127194941 | 12719494 | 24 | C | PL | ACETAMINOPHENCAFFEINEPROMETHAZINESALICYLAMIDE | 1 | Oral | 0 | 1 | G | TID | ||||||||
127194941 | 12719494 | 25 | C | CALONAL | ACETAMINOPHEN | 1 | Oral | 400-1200 MG/DAY, DIVIDED INTO THREE TIMES AFTER MEALS | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127194941 | 12719494 | 1 | Product used for unknown indication |
127194941 | 12719494 | 5 | Pemphigoid |
127194941 | 12719494 | 6 | Product used for unknown indication |
127194941 | 12719494 | 9 | Inflammation |
127194941 | 12719494 | 21 | Prophylaxis against gastrointestinal ulcer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127194941 | 12719494 | OT |
127194941 | 12719494 | HO |
127194941 | 12719494 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127194941 | 12719494 | Cytomegalovirus infection | |
127194941 | 12719494 | Drug hypersensitivity | |
127194941 | 12719494 | Drug reaction with eosinophilia and systemic symptoms | |
127194941 | 12719494 | Pancytopenia | |
127194941 | 12719494 | Pneumocystis jirovecii pneumonia | |
127194941 | 12719494 | Pyrexia | |
127194941 | 12719494 | Quality of life decreased | |
127194941 | 12719494 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127194941 | 12719494 | 1 | 20130326 | 20130408 | 0 | |
127194941 | 12719494 | 2 | 20130612 | 20130628 | 0 | |
127194941 | 12719494 | 3 | 20130724 | 20130812 | 0 | |
127194941 | 12719494 | 4 | 20131003 | 20131007 | 0 | |
127194941 | 12719494 | 5 | 20121219 | 20130201 | 0 | |
127194941 | 12719494 | 6 | 20120321 | 20120618 | 0 | |
127194941 | 12719494 | 7 | 20120807 | 20121128 | 0 | |
127194941 | 12719494 | 8 | 20130201 | 20130319 | 0 | |
127194941 | 12719494 | 9 | 20120918 | 20130318 | 0 | |
127194941 | 12719494 | 10 | 20130319 | 20130409 | 0 | |
127194941 | 12719494 | 11 | 20130410 | 20130416 | 0 | |
127194941 | 12719494 | 12 | 20130417 | 20130424 | 0 | |
127194941 | 12719494 | 13 | 20130425 | 20130508 | 0 | |
127194941 | 12719494 | 14 | 20130509 | 20130515 | 0 | |
127194941 | 12719494 | 15 | 20130516 | 20130522 | 0 | |
127194941 | 12719494 | 16 | 20130523 | 20130528 | 0 | |
127194941 | 12719494 | 17 | 20130529 | 20130613 | 0 | |
127194941 | 12719494 | 18 | 20130614 | 0 | ||
127194941 | 12719494 | 20 | 20120817 | 20130318 | 0 | |
127194941 | 12719494 | 21 | 20120918 | 0 | ||
127194941 | 12719494 | 22 | 20130328 | 20130330 | 0 | |
127194941 | 12719494 | 23 | 20121211 | 20130201 | 0 | |
127194941 | 12719494 | 24 | 20130130 | 20130201 | 0 | |
127194941 | 12719494 | 25 | 20130201 | 0 |